These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 30509240)

  • 1. The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer.
    Zarkesh M; Zadeh-Vakili A; Akbarzadeh M; Fanaei SA; Hedayati M; Azizi F
    BMC Cancer; 2018 Dec; 18(1):1199. PubMed ID: 30509240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic utility of TROP-2, SLP-2, and CXCL12 expression in papillary thyroid carcinoma.
    Attia AS; Hussein S; Sameh H; Khalil A; Waley AB; Matar I; Sameh R
    Cancer Biomark; 2024; 39(3):211-221. PubMed ID: 38073379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial DNA copy number and risk of papillary thyroid carcinoma.
    Alwehaidah MS; Al-Awadhi R; Roomy MA; Baqer TA
    BMC Endocr Disord; 2024 Aug; 24(1):138. PubMed ID: 39090709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing Angioinvasion Assessment in Papillary Thyroid Cancer Via a Biomarker Panel Involving TAC, 8-OHdG, and Sortilin.
    Buczyńska A; Kościuszko M; Sidorkiewicz I; Wiatr AA; Adamska A; Siewko K; Dzięcioł J; Szelachowska M; Krętowski AJ; Popławska-Kita A
    J Clin Endocrinol Metab; 2024 Jun; 109(7):1866-1872. PubMed ID: 38181425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of rs2236242 at SERPINA12 gene and vaspin level on papillary thyroid carcinoma.
    Torki S; Nezhadali M; Hedayati M; Karimi H; Razavi SA; Najd Hassan Bonab L
    Nucleosides Nucleotides Nucleic Acids; 2024 May; ():1-12. PubMed ID: 38781583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between integrin β4 overexpression and lymphovascular invasion in papillary thyroid cancer.
    Topuz BT; Guldiken S; Tastekin E; Topuz C; Celik M; Bulbul BY; Andac B; Yekdes AC
    Endokrynol Pol; 2024; 75(3):310-316. PubMed ID: 38887115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma metabolites analysis of patients with papillary thyroid cancer: A preliminary untargeted
    Razavi SA; Mahmanzar M; Nobakht M Gh BF; Zamani Z; Nasiri S; Hedayati M
    J Pharm Biomed Anal; 2024 Apr; 241():115946. PubMed ID: 38241910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adolescent overweight and obesity and the risk of papillary thyroid cancer in adulthood: a large-scale case-control study.
    Kim KN; Hwang Y; Kim KH; Lee KE; Park YJ; Kim SJ; Kwon H; Park DJ; Cho B; Choi HC; Kang D; Park SK
    Sci Rep; 2020 Mar; 10(1):5000. PubMed ID: 32193459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From balance to imbalance: disruption of plasma glutathione concentration in micropapillary thyroid carcinoma.
    Eskandari F; Hedayati M; Tavangar SM; Rezaei F; Khodagholipour A; Razavi SA
    Thyroid Res; 2024 Jul; 17(1):16. PubMed ID: 38946003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occupational daily walking steps have inverse relationship with papillary thyroid cancer risk and progression: a retrospective analysis.
    Zhang C; Zhang L; Su Y; Xiang L; Zhang Q; Zhang C; Huan Q
    Int J Occup Med Environ Health; 2024 Mar; 37(1):58-71. PubMed ID: 38406822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality among papillary thyroid cancer patients by detection route: a hospital-based retrospective cohort study.
    Wu L; Vaccarella S; Feng CY; Dal Maso L; Chen Y; Liu WW; Liang MB; Zhang Z; Yang J; Cao SM; Li M
    Eur Thyroid J; 2023 Dec; 12(6):. PubMed ID: 37855414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarker Discovery for Early Diagnosis of Papillary Thyroid Carcinoma Using High-Throughput Enhanced Quantitative Plasma Proteomics.
    Lu H; Pan Y; Ruan Y; Zhu C; Hassan HM; Gao J; Gao J; Fan L; Liang X; Wang H; Ying S; Chen Q
    J Proteome Res; 2023 Oct; 22(10):3200-3212. PubMed ID: 37624590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix Metalloproteinase 9/microRNA-145 Ratio: Bridging Genomic and Immunological Variabilities in Thyroid Cancer.
    Toraih EA; Hussein MH; Al Ageeli E; Ellaban M; Kattan SW; Moroz K; Fawzy MS; Kandil E
    Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38001954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncovering the pathogenesis of obesity complicated with papillary thyroid carcinoma via bioinformatics and experimental validation.
    Yuan K; Hu D; Mo X; Zeng R; Wu B; Zhang Z; Hu R; Wang C
    Aging (Albany NY); 2023 Sep; 15(17):8729-8743. PubMed ID: 37671970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of MMP-9 and MMP-9 Inhibition in Different Types of Thyroid Carcinoma.
    Li Z; Wei J; Chen B; Wang Y; Yang S; Wu K; Meng X
    Molecules; 2023 Apr; 28(9):. PubMed ID: 37175113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unfolding of Imminent Bio-Signatures in the Prognosis of Thyroid Cancer; The Emergence of Estrogen Related Receptor Gamma (ERRγ) as a Hurricane.
    Gulwani D; Upadhyay P; Goel R; Sarangthem V; Debraj Singh T
    Asian Pac J Cancer Prev; 2023 Feb; 24(2):375-387. PubMed ID: 36853284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. To Explore the Inhibitory Mechanism of Quercetin in Thyroid Papillary Carcinoma through Network Pharmacology and Experiments.
    Sun Y; Xie W; Kang N; Yi J; Ruan X; Hu L; Zhao J; Zheng X; Wei S; Gao M
    Dis Markers; 2022; 2022():9541080. PubMed ID: 36510497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of CERK and SPHK1 in breast cancer and their association with metastasis and drug resistance.
    Bhadwal P; Randhawa V; Vaiphei K; Dahiya D; Agnihotri N
    Sci Rep; 2022 Oct; 12(1):18239. PubMed ID: 36309544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of stromal biomarkers in small papillary thyroid carcinomas.
    Bayadsi H; Barghout G; Gustafsson M; Sund M; Hennings J
    World J Surg Oncol; 2022 Oct; 20(1):340. PubMed ID: 36242015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive Significance of Two MMP-9 Promoter Polymorphisms and Acetylated c-Jun Transcription Factor for Papillary Thyroid Carcinoma Advancement.
    Rončević J; Janković Miljuš J; Išić Denčić T; Božić V; Živaljević V; Šelemetjev S; Đorić I
    Diagnostics (Basel); 2022 Aug; 12(8):. PubMed ID: 36010303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.